000947100 000__ 04707cam\a2200493Mi\4500
000947100 001__ 947100
000947100 005__ 20230306152652.0
000947100 006__ m\\\\\o\\d\\\\\\\\
000947100 007__ cr\nn\nnnunnun
000947100 008__ 201209s2020\\\\si\\\\\\o\\\\\|||\0\eng\d
000947100 019__ $$a1226761257
000947100 020__ $$a9811562555
000947100 020__ $$a9789811562556
000947100 020__ $$z9811562547
000947100 020__ $$z9789811562549
000947100 0247_ $$a10.1007/978-981-15-6255-6$$2doi
000947100 035__ $$aSP(OCoLC)on1228649878
000947100 035__ $$aSP(OCoLC)1228649878$$z(OCoLC)1226761257
000947100 040__ $$aSFB$$beng$$cSFB$$dOCLCO$$dYDX
000947100 049__ $$aISEA
000947100 050_4 $$aQH506
000947100 08204 $$a611.01816$$223
000947100 24500 $$aNano Medicine and Nano Safety:$$bRecent Trends and Clinical Evidences /$$cedited by Malay K. Das, Yashwant V. Pathak.
000947100 250__ $$a1st ed. 2020.
000947100 264_1 $$aSingapore :$$bSpringer Singapore :$$bImprint: Springer,$$c2020.
000947100 300__ $$a1 online resource (XVI, 635 pages 57 illus., 34 illus. in color.)
000947100 336__ $$atext$$btxt$$2rdacontent
000947100 337__ $$acomputer$$bc$$2rdamedia
000947100 338__ $$aonline resource$$bcr$$2rdacarrier
000947100 5050_ $$aPart A: Applications of Nano Biotechnology in the development of Nano Medicine -- Chapter 1. Nanobiotechnology and its application in Nanomedicine: An Overview -- Chapter 2. Nanobiotechnology for therapeutic targeting of circulating tumor cells in the blood -- Chapter 3. Application of Nanobiotechnology in clinical diagnosis -- Chapter 4. Anti-diabetic Nano formulation from herbal source -- Chapter 5. Nanomaterials for alternative antibiotic therapy -- Part B: Nano Medicine: concept, development, clinical applications and evidences -- Chapter 6. Nano medicines and Nano drug delivery systems: trends and perspectives -- Chapter 7. Nano medicines in drug delivery from synthetic/natural sources to their clinical applications -- Chapter 8. Transdermal Nanomedicines for Reduction of Dose And Site-Specific Drug Delivery -- Chapter 9. Multifunctional mesoporous silica nanoparticles for biomedical applications -- Chapter 10. Advances in pulmonary Nano medicine for therapeutic management of respiratory diseases -- Chapter 11. Nanoemulsion Delivery of Herbal Products: Prospects and Challenges -- Chapter 12. Stimuli-responsive polymers for cancer Nano medicines -- Chapter 13. Carbohydrate-Derived Tailorable Interfaces: Recent Advances and Applications -- Chapter 14. Multifunctional Nano scale particles for theranostic application in healthcare -- Chapter 15. Ligand nanoparticle conjugation approach for targeted cancer chemotherapy -- Chapter 16. Tunable Biopolymeric Drug Carrier Nanovehicles and Their Safety -- Chapter 17. Nano medicine for challenging solid tumors: Recent trends and future ahead -- Part C: Regulatory, safety and marketing aspects of Nano Medicine -- Chapter 18. Recent trends for Nano medicine safety -- Chapter 19. Nano toxicity and risk assessment of Nano medicines -- Chapter 20. Clinical toxicity of Nano medicines -- Chapter 21. Nano Medicine: Risk, Regulation, Safety and Public Health -- Chapter 22. New deliveries and nanomedicines: Commercial aspects and business perspectives -- Chapter 23. Global growth of Nano medicines and what role it will play for economically weak countries.
000947100 506__ $$aAccess limited to authorized users.
000947100 520__ $$aThis book reviews the application of Nanobiotechnology in the development of Nanomedicine, while also discussing the latest trends and challenges in the clinical translation of Nanomedicine. Nanomedicine refers to the application of Nanotechnology to medicine and holds tremendous potential for achieving improved efficiency, bioavailability, dose response, personalized medicine and enhanced safety as compared to conventional medicines. The book first introduces readers to the basic concepts of Nanomedicine, and to technological advances in and applications of Nanotechnology in treatment, diagnosis, monitoring, and drug delivery. In turn, it reviews the current status of multi-functionalization strategies for using Nanoparticles in the targeted delivery of therapeutic agents. The book's third and final section focuses on the regulatory and safety challenges posed by Nanomedicine, including industry and regulatory agencies' efforts to address them.
000947100 650_0 $$aMolecular biology.
000947100 650_0 $$aNanotechnology.
000947100 650_0 $$aPharmaceutical technology.
000947100 650_0 $$aBiomedical engineering.
000947100 650_0 $$aMedicine.
000947100 7001_ $$aDas, Malay K.$$eeditor.
000947100 7001_ $$aPathak, Yashwant V.$$eeditor.
000947100 77608 $$iPrint version: $$z981-15-6254-7
000947100 852__ $$bebk
000947100 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-981-15-6255-6$$zOnline Access$$91397441.1
000947100 909CO $$ooai:library.usi.edu:947100$$pGLOBAL_SET
000947100 980__ $$aEBOOK
000947100 980__ $$aBIB
000947100 982__ $$aEbook
000947100 983__ $$aOnline
000947100 994__ $$a92$$bISE